ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO1020

Effect of Short-Duration Pretransplant Dialysis on Kidney Transplant Outcomes: A Mate-Kidney Analysis

Session Information

Category: Transplantation

  • 2002 Transplantation: Clinical

Authors

  • Sureshkumar, Kalathil K., Allegheny Health Network, Pittsburgh, Pennsylvania, United States
  • Daloul, Reem, Allegheny Health Network, Pittsburgh, Pennsylvania, United States
  • McGill, Rita L., The University of Chicago, Chicago, Illinois, United States

Group or Team Name

  • AHN
Background

Pre-emptive kidney transplant provides superior long-term graft and patient outcomes compared to transplant following long-term pre-transplant dialysis. We used a mate-kidney model to clarify the impact of short-duration dialysis exposure on patient and graft survival by matching for donor variables.

Methods

UNOS STAR files were used to identify deceased donors between 2000-2024 from whom one kidney was transplanted into a recipient on maintenance pre-transplant dialysis for ≤ 6 months and the mate-kidney was transplanted pre-emptively. Models were adjusted for recipient (age, gender, race, private insurance, peripheral vasular disease, cancer history, panel reactive antibody titer) and transplantation (transplant center distance, use of left kidney, cold ischemia time, pump perfusion, ABO compatibility, HLA and DR mismatches) variables.

Results

We identified 846 recipients of 423 deceased donors. Median follow up was 48 (IQR=14-108) months. Median dialysis duration in the dialysis group was 3.6 (IQR=1.8-5.1) months. Pre-emptive kidney transplant recipients (KTRs) were older (56±13 vs. 53±14 years, p<0.001), had more private insurance (59% vs. 53%, p=0.048), and less freqently received lymphocyte depleting induction (56% vs. 62%, p=0.03) and mycophenolic acid (80% vs. 85%, p=0.034). Compared to KTRs receiving ≤ 6 months dialysis, pre-emptive KTRs had less graft failure (22.9% vs. 30.7%, p=0.01), and longer median graft survival (48 vs. 40 months, p=0.04). Risk of death and median survival did not differ between paired recipients. Hazard ratios are shown in the table. Pre-emptive transplant status reduced graft failure risk by 47%. Age and private insurance were the only adjustors that affected patient survival.

Conclusion

Our findings in a mate-kidney model suggest that the metabolic, inflammatory and immunologic perturbations associated with pre-transplant dialysis may have adverse impact on graft outcomes even when dialysis exposure is brief.

Adjusted models for transplant outcomes
VariableUncensored graft failureDeath
Hazard Ratio (95% CI)PHazard Ratio (95% CI)P
Pre-emptive transplant0.53 (0.35, 0.79)0.0020.77 (0.48, 1.24)0.28
Age, per 10 years1.44 (1.09, 1.90)0.0092.28 (1.56, 3.33)<0.001
Private insurance0.42 (0.20, 0.86)0.0180.45 (0.20, 1.00)0.045

CI = Confidence interval